CTRE vs DX
CareTrust REIT vs Dynex Capital, Inc. — AI-powered side-by-side comparison
CTRE
CareTrust REIT
68
Buy
VS
DX
Dynex Capital, Inc.
61
Buy
| Metric | CTRE | DX |
|---|
| AI Score |
68
|
61
|
| Price |
$38.70
|
$12.94
|
| P/E Ratio |
24.33×
|
4.88×
|
| ROE |
7.9%
|
13.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
78.0%
|
76.4%
|
| Debt / Equity |
0.27×
|
7.13×
|
| Dividend Yield |
3.7%
|
15.8%
|
| RSI (14) |
32.6
|
55.3
|
| Beta |
0.8
|
0.935
|
| Expected Upside |
+2.7%
|
—
|
AI Committee View
Current Innellis committee reasoning for CTRE versus DX.
CTRE leads by 7 points.
CTRE scores 68/100 (Buy) versus DX at 61/100 (Buy).
CTRE Committee View
67% agreement
6 analysts
The primary driver is revenue growing 53.0% yoy -- genuine top-line momentum. The main limiting factor is p/e of 27.4 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- Dividend yield of 3.9% pays you to wait — Value
- Revenue growing 53.0% YoY -- genuine top-line momentum — Growth
- EPS growing 32.2% YoY — Growth
Bear Case
- P/E of 27.4 is moderate-to-rich — Value
- MACD histogram negative -- bearish momentum — Technical
DX Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 136.4% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 5.65) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 7.2 is inexpensive for the broad market — Value
- Price-to-book of 0.8x is a discount to asset value — Value
- ROE of 16.9% shows genuine earnings power backing the valuation — Value
Bear Case
- Debt-to-equity of 5.65 adds balance-sheet risk to the value case — Value
- Price structure making lower highs and lower lows — Technical
- Daily trend (downtrend) conflicts with the weekly trend (uptrend) -- fighting the larger trend — Technical